The Scientific Team at RAPT Therapeutics is dedicated to advancing the company's mission of developing innovative oral small molecule therapies for oncology and inflammatory diseases. This team engages in comprehensive research and development activities, including drug discovery, biomarker development, preclinical studies, and computational biology, to identify and optimize novel therapeutic candidates. They work on translating scientific discoveries into clinical-stage products to meet significant unmet medical needs.
Alexander Rudensky
Chairman, Scientific Advisory ...
Antoni Ribas
Scientific Advisor
David Wustrow
Sen. VP Discovery And Preclini...
Dirk Brockstedt
Chief Scientific Officer
Drew M. Pardoll
Scientific Advisor
Emma Guttman-Yassky
Scientific Advisor
Lawrence Fong
Scientific Advisor
Philip Greenberg
Scientific Advisor
Robert Zamboni
Scientific Advisor
Scott Joseph Antonia
Scientific Advisor
View all